NHS Test Bed Sites for Innovation Adoption Announced
Posted on January 25, 2016
NHS England has announced the five centres that have been awarded the status of Innovation Test Beds in which new approaches to healthcare provision will be assessed and adopted and two centres for the adoption of the Internet of Things (IoT) in healthcare.
Aseptika is pleased to announce that it is one of the innovators partnering with the Test Bed programme in Sheffield for the trial and integration of its Activ8rlives solution for patients with respiratory disease into the new pathways of care.
Test Beds are a new collaborations between the NHS and innovators like Aseptika, which aim to harness technology to address some of the most complex and challenging issues facing patients and the health service.
Successful innovations will then be available for other parts of the NHS to adopt and adapt to the particular needs of their local populations.
The ‘Perfect Patient Pathway’, as the Sheffield City region Test Bed will be known, aims to create the ‘perfect patient pathway’ to bring substantial benefits for patients suffering from long term health conditions, such as diabetes, mental health problems, respiratory diseases, hypertension and other chronic conditions.
About Sheffield Teaching Hospitals NHS Foundation Trust
View the Media Release about Sheffield’s Perfect Patient Pathway test bed by following this link.
For press information, please contact:
Jessica Auton, Marketing Director,
Direct +44 (0)1480 352 821
Mobile +44 (0)7455 922 122
Free-For-Life Healthcare Self-Management Activ8rlives4 Health+Wellness App Update
Posted on August 11, 2021
Stigma: an unmet public health priority in COPD
Posted on June 30, 2021
Latest guidance from GPs about using pulse oximetry to help if you catch COVID-19
Posted on January 12, 2021
The changing face of cardiac rehab: How health technology has improved the way cardiac patients access vital rehabilitation services
Posted on November 16, 2020
Taking Cardiac Rehab Online during Lockdown
Posted on September 14, 2020